Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaru Zou

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
American Journal of Physiology. Cell Physiology|December 19, 2014
The topoisomerase II catalytic inhibitor ICRF-193 preferentially targets telomeres that are capped by TRF2Lianxiang Chen, Xiaowei Zhu, Yaru Zou, et al.
The Journal of Investigative Dermatology|March 20, 2021
The Pathogenic Role of CD4<sup>+</sup> Tissue-Resident Memory T Cells Bearing T Follicular Helper-Like Phenotype in Pemphigus LesionsYaru Zou, Huijie Yuan, Shengru Zhou, et al.
Microbial Pathogenesis|July 19, 2015
The effects of D-Tyrosine combined with amikacin on the biofilms of Pseudomonas aeruginosaPengfei She, Lihua Chen, Hongbo Liu, et al.
BMC Psychology|February 3, 2026
Effects of gender differences and lifestyle factors on depression among Chinese children and adolescentsRong Liu, Qian Lyu, Xinyue Liu, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 29, 2025
Burden of macular complications in Japanese patients aged 75 years and over with sarcoid uveitisYuan Zong, Koju Kamoi, Jing Zhang, et al.
Viruses|September 28, 2024
Cytomegalovirus Retinitis: Clinical Manifestations, Diagnosis and TreatmentJing Zhang, Koju Kamoi, Yuan Zong, et al.
International Journal of Molecular Sciences|September 14, 2024
Applications of Biological Therapy for Latent Infections: Benefits and RisksYuan Zong, Koju Kamoi, Miki Miyagaki, et al.
Antibodies (Basel, Switzerland)|October 25, 2024
Ophthalmic Use of Targeted Biologics in the Management of Intraocular Diseases: Current and Emerging TherapiesYuan Zong, Miki Miyagaki, Mingming Yang, et al.
Pathogens (Basel, Switzerland)|October 25, 2024
Ocular Toxoplasmosis: Advances in <i>Toxoplasma gondii</i> Biology, Clinical Manifestations, Diagnostics, and TherapyMiki Miyagaki, Yuan Zong, Mingming Yang, et al.
International Immunopharmacology|August 13, 2023
Microbiome changes involves in mercaptopurine mediated anti-inflammatory response in acute lymphoblastic leukemia miceSiyao Jin, Jiamin Xu, Yaru Zou, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
American Journal of Physiology. Cell Physiology|December 19, 2014
The topoisomerase II catalytic inhibitor ICRF-193 preferentially targets telomeres that are capped by TRF2Lianxiang Chen, Xiaowei Zhu, Yaru Zou, et al.
The Journal of Investigative Dermatology|March 20, 2021
The Pathogenic Role of CD4<sup>+</sup> Tissue-Resident Memory T Cells Bearing T Follicular Helper-Like Phenotype in Pemphigus LesionsYaru Zou, Huijie Yuan, Shengru Zhou, et al.
Microbial Pathogenesis|July 19, 2015
The effects of D-Tyrosine combined with amikacin on the biofilms of Pseudomonas aeruginosaPengfei She, Lihua Chen, Hongbo Liu, et al.
BMC Psychology|February 3, 2026
Effects of gender differences and lifestyle factors on depression among Chinese children and adolescentsRong Liu, Qian Lyu, Xinyue Liu, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 29, 2025
Burden of macular complications in Japanese patients aged 75 years and over with sarcoid uveitisYuan Zong, Koju Kamoi, Jing Zhang, et al.
Viruses|September 28, 2024
Cytomegalovirus Retinitis: Clinical Manifestations, Diagnosis and TreatmentJing Zhang, Koju Kamoi, Yuan Zong, et al.
International Journal of Molecular Sciences|September 14, 2024
Applications of Biological Therapy for Latent Infections: Benefits and RisksYuan Zong, Koju Kamoi, Miki Miyagaki, et al.
Antibodies (Basel, Switzerland)|October 25, 2024
Ophthalmic Use of Targeted Biologics in the Management of Intraocular Diseases: Current and Emerging TherapiesYuan Zong, Miki Miyagaki, Mingming Yang, et al.
Pathogens (Basel, Switzerland)|October 25, 2024
Ocular Toxoplasmosis: Advances in <i>Toxoplasma gondii</i> Biology, Clinical Manifestations, Diagnostics, and TherapyMiki Miyagaki, Yuan Zong, Mingming Yang, et al.
International Immunopharmacology|August 13, 2023
Microbiome changes involves in mercaptopurine mediated anti-inflammatory response in acute lymphoblastic leukemia miceSiyao Jin, Jiamin Xu, Yaru Zou, et al.
Pageof 5